Analyst · Regeneron Pharmaceuticals, Inc. (REGN) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy60 analysts

Buy

Updated Jul 26, 2026

Total Analysts60

Buy

34

Hold

15

Ratings

Updated Jul 26, 2026

Overall Rating

A

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$656.01

Median Target+22.80%

$805.55

Potential upside vs current price

Analyst Consensus

Buy60 analysts

Buy

Updated Jul 26, 2026

Total Analysts60

Buy

34

Hold

15

Ratings

Updated Jul 26, 2026

Overall Rating

A

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$656.01

Median Target+22.80%

$805.55

Potential upside vs current price